growth
-
Vetter prepares for further growth
As part of its business growth strategy, Vetter has announced that a triple-digit million euro syndicated loan has been arranged with a consortium of banks led by Deutsche Bank AG, the Landesbank Baden-Württemberg, and Commerzbank AG.
growth | 25 May 2012
-
Refinements in inhaled drug delivery enhances growth prospects as global markets emerge
Survey finds evolving device technologies creating opportunities for drug developers, according to Greystone Research Associates.
growth | 10 April 2012
-
Emphasis on reconstituting drugs at the point-of-care driven by growth in lyophilized drugs
The push to intuitive technology is seen as reducing medication errors according to Greystone Research Associates.
growth | 14 March 2012
-
Fentanyl growth set to reach double digits
Greystone Research associates analyze the demographic, economic, pharmaceutical and morbidity factors driving demand.
growth | 30 November 2011
-
Novartis increases growth potential through integration of Alcon
Alcon is innovative new growth platform with leading position in eye care segment.
growth | 13 September 2011
-
Diabetes population in urban China shows considerable growth in last decade
In the past decade, the urban diabetes population in China has grown considerably, according to new research by GfK HealthCare’s Roper Global Diabetes Group. The prevalence of diagnosed diabetes has increased by more than 40 percent and the populat…
growth | 03 June 2011
-
Boehringer Ingelheim to start new growth phase in 2011
2010 was for Boehringer Ingelheim the year in which it reached 125 years of age. The jubilee year also brought new alliances for the future. With Eli Lilly and Company, Boehringer Ingelheim will develop and market active substances for diabetes that …
growth | 09 May 2011
-
Abbott reports strong growth in emerging markets
Healthy performance across Abbott's diverse businesses and emerging markets expansion drove strong and consistent growth in 2010, Chairman and Chief Executive Officer Miles D White told shareholders at the company's annual meeting. "We continued t…
growth | 02 May 2011
-
Bayer HealthCare sees growth in Asia
Bayer HealthCare Pharmaceuticals has increased its sales in Asia Pacific by 5.8 percent to €604 million (US$860 million) in 2010 compared with 2009. This surpasses the global growth of 0.9 percent. The company is pursuing organic and inorganic …
growth | 01 May 2011
-
Australian pharmaceuticals market: Top growth opportunities
Despite Australia being a mature market for pharmaceuticals, there will be steady growth in coming years due to easy public access to its well-managed healthcare system.
growth | 01 May 2011
